A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice
Abstract Background Growth differentiation factor 11 (GDF11) is a member of the transforming growth factor β superfamily. The GDF11 propeptide, which is derived from the GDF11 precursor protein, blocks the activity of GDF11 and its homolog, myostatin, which are both potent inhibitors of muscle growt...
Main Authors: | Quan Jin, Chunping Qiao, Jianbin Li, Bin Xiao, Juan Li, Xiao Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Skeletal Muscle |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13395-019-0197-y |
Similar Items
-
A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys
by: Michael St. Andre, et al.
Published: (2017-11-01) -
Functional replacement of myostatin with GDF-11 in the germline of mice
by: Se-Jin Lee, et al.
Published: (2022-03-01) -
Lipidomic Analyses Reveal Specific Alterations of Phosphatidylcholine in Dystrophic Mdx Muscle
by: William J. Valentine, et al.
Published: (2022-01-01) -
Diminution in sperm quantity and quality in mouse models of Duchenne Muscular Dystrophy induced by a myostatin-based muscle growth-promoting intervention
by: Danielle Vaughan, et al.
Published: (2020-06-01) -
Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone
by: Andrea Iskenderian, et al.
Published: (2018-10-01)